BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 31636246)

  • 21. Metformin ameliorates doxorubicin-induced cardiotoxicity targeting HMGB1/TLR4/NLRP3 signaling pathway in mice.
    Alzokaky AA; Al-Karmalawy AA; Saleh MA; Abdo W; Farage AE; Belal A; Abourehab MAS; Antar SA
    Life Sci; 2023 Mar; 316():121390. PubMed ID: 36649752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protease-activated receptor 1 activation enhances doxorubicin-induced cardiotoxicity.
    Antoniak S; Tatsumi K; Schmedes CM; Grover SP; Pawlinski R; Mackman N
    J Mol Cell Cardiol; 2018 Sep; 122():80-87. PubMed ID: 30098988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exogenous hydrogen sulfide protects against doxorubicin-induced inflammation and cytotoxicity by inhibiting p38MAPK/NFκB pathway in H9c2 cardiac cells.
    Guo R; Wu K; Chen J; Mo L; Hua X; Zheng D; Chen P; Chen G; Xu W; Feng J
    Cell Physiol Biochem; 2013; 32(6):1668-80. PubMed ID: 24356372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Astragaloside IV attenuates injury caused by myocardial ischemia/reperfusion in rats via regulation of toll-like receptor 4/nuclear factor-κB signaling pathway.
    Lu M; Tang F; Zhang J; Luan A; Mei M; Xu C; Zhang S; Wang H; Maslov LN
    Phytother Res; 2015 Apr; 29(4):599-606. PubMed ID: 25604645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Natural compound glycyrrhetinic acid protects against doxorubicin-induced cardiotoxicity by activating the Nrf2/HO-1 signaling pathway.
    Cheng Y; Wu X; Nie X; Wu Y; Zhang C; Lee SM; Lv K; Leung GP; Fu C; Zhang J; Li J
    Phytomedicine; 2022 Nov; 106():154407. PubMed ID: 36070662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exogenous Hydrogen Sulfide Attenuates High Glucose-Induced Cardiotoxicity by Inhibiting NLRP3 Inflammasome Activation by Suppressing TLR4/NF-κB Pathway in H9c2 Cells.
    Huang Z; Zhuang X; Xie C; Hu X; Dong X; Guo Y; Li S; Liao X
    Cell Physiol Biochem; 2016; 40(6):1578-1590. PubMed ID: 27997926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tirzepatide protects against doxorubicin-induced cardiotoxicity by inhibiting oxidative stress and inflammation via PI3K/Akt signaling.
    Chen L; Chen X; Ruan B; Yang H; Yu Y
    Peptides; 2024 Aug; 178():171245. PubMed ID: 38801993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Meteorin-like protein attenuates doxorubicin-induced cardiotoxicity via activating cAMP/PKA/SIRT1 pathway.
    Hu C; Zhang X; Song P; Yuan YP; Kong CY; Wu HM; Xu SC; Ma ZG; Tang QZ
    Redox Biol; 2020 Oct; 37():101747. PubMed ID: 33045622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of Kininogen-1 aggravates oxidative stress and mitochondrial dysfunction in DOX-induced cardiotoxicity.
    Cheng X; Liu D; Song H; Tian X; Yan C; Han Y
    Biochem Biophys Res Commun; 2021 Apr; 550():142-150. PubMed ID: 33706097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Irbesartan suppresses cardiac toxicity induced by doxorubicin via regulating the p38-MAPK/NF-κB and TGF-β1 pathways.
    El-Said NT; Mohamed EA; Taha RA
    Naunyn Schmiedebergs Arch Pharmacol; 2019 Jun; 392(6):647-658. PubMed ID: 30734091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Berberine Alleviates Doxorubicin-Induced Myocardial Injury and Fibrosis by Eliminating Oxidative Stress and Mitochondrial Damage via Promoting Nrf-2 Pathway Activation.
    Wang Y; Liao J; Luo Y; Li M; Su X; Yu B; Teng J; Wang H; Lv X
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sirt6 protects cardiomyocytes against doxorubicin-induced cardiotoxicity by inhibiting P53/Fas-dependent cell death and augmenting endogenous antioxidant defense mechanisms.
    Wu S; Lan J; Li L; Wang X; Tong M; Fu L; Zhang Y; Xu J; Chen X; Chen H; Li R; Wu Y; Xin J; Yan X; Li H; Xue K; Li X; Zhuo C; Jiang W
    Cell Biol Toxicol; 2023 Feb; 39(1):237-258. PubMed ID: 34713381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Promising cardioprotective effect of baicalin in doxorubicin-induced cardiotoxicity through targeting toll-like receptor 4/nuclear factor-κB and Wnt/β-catenin pathways.
    El-Ela SRA; Zaghloul RA; Eissa LA
    Nutrition; 2022 Oct; 102():111732. PubMed ID: 35816809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ferritin heavy chain as main mediator of preventive effect of metformin against mitochondrial damage induced by doxorubicin in cardiomyocytes.
    Asensio-Lopez MC; Sanchez-Mas J; Pascual-Figal DA; de Torre C; Valdes M; Lax A
    Free Radic Biol Med; 2014 Feb; 67():19-29. PubMed ID: 24231192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel compound DT-010 protects against doxorubicin-induced cardiotoxicity in zebrafish and H9c2 cells by inhibiting reactive oxygen species-mediated apoptotic and autophagic pathways.
    Tang F; Zhou X; Wang L; Shan L; Li C; Zhou H; Lee SM; Hoi MP
    Eur J Pharmacol; 2018 Feb; 820():86-96. PubMed ID: 29229534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of Nrf2 by miR-152 Inhibits Doxorubicin-Induced Cardiotoxicity via Attenuation of Oxidative Stress, Inflammation, and Apoptosis.
    Zhang WB; Lai X; Guo XF
    Oxid Med Cell Longev; 2021; 2021():8860883. PubMed ID: 33574984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiR-200a-3p Aggravates DOX-Induced Cardiotoxicity by Targeting PEG3 Through SIRT1/NF-κB Signal Pathway.
    Fu Q; Pan H; Tang Y; Rong J; Zheng Z
    Cardiovasc Toxicol; 2021 Apr; 21(4):302-313. PubMed ID: 33638775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tanshinone I inhibits doxorubicin-induced cardiotoxicity by regulating Nrf2 signaling pathway.
    Jiang Q; Chen X; Tian X; Zhang J; Xue S; Jiang Y; Liu T; Wang X; Sun Q; Hong Y; Li C; Guo D; Wang Y; Wang Q
    Phytomedicine; 2022 Nov; 106():154439. PubMed ID: 36108374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cathepsin B aggravated doxorubicin‑induced myocardial injury via NF‑κB signalling.
    Liu C; Cai Z; Hu T; Yao Q; Zhang L
    Mol Med Rep; 2020 Dec; 22(6):4848-4856. PubMed ID: 33173960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protective Role of GPER Agonist G-1 on Cardiotoxicity Induced by Doxorubicin.
    De Francesco EM; Rocca C; Scavello F; Amelio D; Pasqua T; Rigiracciolo DC; Scarpelli A; Avino S; Cirillo F; Amodio N; Cerra MC; Maggiolini M; Angelone T
    J Cell Physiol; 2017 Jul; 232(7):1640-1649. PubMed ID: 27607345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.